24 Mar Addressing Rigor and Reproducibility in Your NIH Grant
Beginning in 2016, NIH has required that the rigor and reproducibility of the proposed project be addressed in grant submissions. This session will describe why the inability to reproduce data in published studies has increased, the implications for science, and ways to improve the rigor and reproducibility of studies. In addition, we will discuss tips for addressing rigor and reproducibility requirements in grant submissions.
Event Materials4 MBPRESENTATION – Addressing Rigor and Reproducibility in Your NIH Grant
At the end of the session, participants will be able to:
- Understand why lack of reproducibility in science is a problem.
- Describe strategies to minimize irreproducibility and increase rigor.
- Describe the factors that lead to a lack of reproducibility.
Attendees may wish to download the “Reproducibility and Replicability in Science” report from The National Academies Press as a reference document (not a required pre-read).3 MBHANDOUT – Rigor and Reproducibility
Schedule of Activities
- 12:00-12:10pm – Welcome, Overview, Introductions
- 12:10-1:25pm – Presentation, Interactivity, Q&A
- 1:25-1:30pm – Thank You and Feedback Survey
About the Speaker
Dr. Andrea Lazarus is a clinical professor and Associate Dean for Research in the WSU College of Pharmacy and also serves as Associate Vice President for Health Sciences at WSU, and as Executive Director of the Steve Gleason Institute for Neuroscience. Andrea was previously administrator of the National Institutes of Health-funded Penn State Clinical and Translational Science Institute, and of the Penn State Cancer Institute. She has a PhD in experimental medicine from McGill University, a master’s degree in cell biology from Cornell University and a bachelor’s degree in human genetics from McGill.